Global /Vietnam /Healthcare /Drug Manufacturers - General /DBT

Ben Tre Pharmaceutical JSC

DBT

• HOSE: DBT • Delayed

11,400VND 0%

0.4329 USD

As of 5 June 2026, Ben Tre Pharmaceutical JSC has a market cap of $9.51M USD, ranking #41561 globally and #516 in Vietnam. It ranks #3683 in the Healthcare sector, and #1199 in the Drug Manufacturers - General industry.

Global Rank

41561

Country Rank

516

Sector Rank

3683

Industry Rank

1199

Key Stats

Market Cap

$9.51MUSD

250.43B VND

Enterprise Value

$28.7MUSD

755.76B VND

Revenue (TTM)

$32.67MUSD

860.31B VND

EBITDA (TTM)

$2.38MUSD

62.68B VND

Net Income (TTM)

$487.95KUSD

12.85B VND

EBITDA Margin

7.3%

Profit Margin

1.7%

PE Ratio

18.6

PS Ratio

0.3

PB Ratio

0.9

EV/EBITDA

12.1

Company Profile

Country (HQ)

Vietnam

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Pham Trieu open_in_new

Employees

781

Founded

1963

Website

bepharco.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	5.6%	10%	3.6%	-1.3%	1.3%	1.7%	26%	27%

News

Markets

Exchange	Ticker	Price	Quotes
Ho Chi Minh Stock Exchange (HOSE) MIC: XSTC PRIMARY	DBT CTCP Dược phẩm Bến Tre ISIN: VN000000DBT6 Shares Out.: Shares Outstanding: 21.967M¹ Shares Float: 14.029M² TV: TradingView: HOSE: DBT SA: Stock Analysis: HOSE: DBT YF: Yahoo Finance: DBT.VN GF: Google Finance: HOSE: DBT BA: Barron's: DBT MS: Morningstar: XSTC: DBT	11,400 VND	TV: TradingView: HOSE: DBT SA: Stock Analysis: HOSE: DBT YF: Yahoo Finance: DBT.VN GF: Google Finance: HOSE: DBT BA: Barron's: DBT MS: Morningstar: XSTC: DBT

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Ben Tre Pharmaceutical JSC

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, anti-inflammatory, on-site impact, and diabetics, as well as herbal medicines. It offers supplements and medical devices. The company was founded in 1963 and is headquartered in Ben Tre, Vietnam.

Similar Companies

Industry: Drug Manufacturers - General (Vietnam)

Name	Market Cap (USD) diff.	PE	Country
DHG Pharmaceutical JSC HOSE: DHG	$496.51M 13.07T VND 5K%	15.0	Vietnam
Imexpharm Corp. HOSE: IMP	$297.1M 7.82T VND 3K%	25.1	Vietnam
Ha Tay Pharmaceutical JSC HNX: DHT	$244.21M 6.43T VND 2K%	110.1	Vietnam
Binh Dinh Pharmaceutical and Medical Equipment JSC HOSE: DBD	$179.05M 4.72T VND 2K%	18.8	Vietnam
Cuu Long Pharmaceutical JSC HOSE: DCL	$103.46M 2.72T VND 988%	139.7	Vietnam
Domesco Medical Import - Export Joint-Stock Corp. HOSE: DMC	$76.49M 2.01T VND 704%	11.6	Vietnam

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 8M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 6M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 4M%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 3M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 3M%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 3M%	20.5	Switzerland

chevron_leftBack